AI Summary
StalkCCEP remains in a Stage 2 advancing regime with medium-term bullish structure intact above the rising 50 DMA, but the recent rejection at the 9 EMA and pullback into the 20 EMA on elevated volume indicates near-term selling pressure. Short-term timing is unfavorable, so defer entries and wait for stable acceptance in the 9/20 EMA support zone before buying.